MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%
Sector Heatmap
Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%
BCRX — BioCryst Pharmaceuticals Inc
NasdaqBioCryst Pharmaceuticals Inc
$8.17
+0.05(+0.62%)
- O
- 8.12
- H
- 8.20
- L
- 7.92
- V
- 5.87M
⏱️ End-of-day dataAs of Oct 2, 2026
BCRX — Financial Statements
Historical 2-Year Statements| Financial Metric / Line Item | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|
| Fiscal Date | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| Period | quarterly | quarterly | quarterly | quarterly | quarterly | quarterly |
| Year | 2,026.00 | 2,025.00 | 2,025.00 | 2,025.00 | 2,025.00 | 2,024.00 |
| Cash And Cash Equivalents | $17.16M | $89.74M | $84.08M | $88.03M | $10.52M | $10.47M |
| Other Short Term Investments | $66.81M | $18.50M | $12.88M | $17.20M | $18.99M | $21.61M |
| Accounts Receivable | $10.93M | $10.68M | $91.33M | $91.18M | $93.39M | $79.07M |
| Inventory | $5.99M | $5.40M | $5.23M | $5.04M | $6.87M | $8.09M |
| Restricted Cash | 854,000.00 | 201,000.00 | 579,000.00 | 492,000.00 | 291,000.00 | 210,000.00 |
| Other Current Assets | $19.11M | $17.18M | $16.50M | $12.54M | $14.33M | $13.75M |
| Total Current Assets | $37.36M | $40.43M | $35.57M | $39.85M | $41.00M | $42.20M |
| Properties | $22.98M | $15.80M | $19.24M | $20.00M | $19.57M | $18.23M |
| Investments And Advances | $20.57M | $61.16M | $39.67M | $10.10M | $20.55M | $20.32M |
| Other Non Current Assets | $47.87M | $29.66M | $31.84M | $28.62M | $29.95M | $28.34M |
| Total Non Current Assets | $91.43M | $10.98M | $90.74M | $58.73M | $70.07M | $68.45M |
| Total Assets | $46.51M | $51.42M | $44.64M | $45.72M | $48.00M | $49.04M |
| Accounts Payable | $10.96M | $15.83M | $5.57M | $8.59M | $10.05M | $11.64M |
| Accrued Expenses | $11.94M | $39.96M | $11.88M | $10.71M | $92.64M | $17.95M |
| Short Term Debt | $3.09M | $1.63M | $1.78M | $2.01M | $2.87M | $2.77M |
| Deferred Revenue | $5.41M | N/A | N/A | N/A | N/A | N/A |
| Other Current Liabilities | $56.53M | $52.20M | $64.11M | $59.45M | $34.30M | $32.68M |
| Total Current Liabilities | $19.54M | $19.61M | $19.02M | $17.72M | $13.99M | $16.04M |
| Long Term Debt | $81.47M | $43.72M | $64.36M | $70.12M | $79.21M | $80.60M |
| Total Non Current Liabilities | $82.35M | $43.72M | $64.41M | $70.16M | $79.21M | $80.60M |
| Total Liabilities | $101.89M | $63.33M | $83.43M | $87.88M | $93.20M | $96.64M |
| Common Stock | $2.54M | $2.13M | $2.10M | $2.10M | $2.09M | $2.08M |
| Retained Earnings | $-222.80M | $-150.62M | $-175.20M | $-176.49M | $-177.00M | $-177.00M |
| Other Shareholders Equity | -368,000.00 | 38,000.00 | $1.14M | $1.65M | $1.13M | 921,000.00 |
| Total Shareholders Equity | $-55.38M | $-11.92M | $-38.79M | $-42.16M | $-45.19M | $-47.59M |
| Additional Paid In Capital | $167.20M | $138.49M | $136.09M | $133.96M | $131.49M | $129.11M |
| Machinery Furniture Equipment | N/A | $2.15M | N/A | N/A | N/A | $3.44M |
| Construction In Progress | N/A | 0.00 | N/A | N/A | N/A | 97,000.00 |
| Leases | N/A | $10.44M | N/A | N/A | N/A | $10.36M |
| Accumulated Depreciation | N/A | $-9.39M | N/A | N/A | N/A | $-12.35M |
| Pensions | N/A | $50.86M | N/A | N/A | N/A | $48.63M |
| Assets Held For Sale | N/A | N/A | $29.17M | $29.17M | N/A | N/A |